1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease : A prospective, multicentre, observational study
(
- Contribution to journal › Article
-
Mark
Baseline Characteristics from Evoke and Evoke+ : Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer's Disease (P11-9.013)
(
- Contribution to journal › Published meeting abstract
- 2023
-
Mark
Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor : a single- and multiple-dose first-in-human study in healthy participants
(
- Contribution to journal › Article
- 2020
-
Mark
The Effect of Cynara scolymus on Blood Pressure and BMI in Hypertensive Patients : A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial
(
- Contribution to journal › Article
- 2018
-
Mark
Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Eruptive syringomas : unresponsiveness to oral isotretinoin
(
- Contribution to journal › Letter
- 2014
-
Mark
Enzalutamide in metastatic prostate cancer before chemotherapy
(
- Contribution to journal › Article
- 2011
-
Mark
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
(
- Contribution to journal › Article
- 2006
-
Mark
Glycemic and non-glycemic effects of pioglitazone in triple oral therapy in patients with type 2 diabetes mellitus
(
- Contribution to journal › Article
- 1997
-
Mark
Parathyroid function and histology in patients with parathyroid adenoma : correlation of clinical and morphologic findings
(
- Contribution to journal › Article